New hope for kids with lupus: drug study shows promise
NCT ID NCT05687526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a drug called telitacicept in 16 children with lupus. The goal was to see how the drug moves through the body and if it helps control the disease. While not a cure, it may offer a new way to manage lupus symptoms in young patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chengdu Women's & Children's Central Hospital
Chengdu, Sichuan, China
-
Children's Hospital of Capital Institute of Pediatrics
Beijing, Beijing Municipality, China
-
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
-
Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
Henan Children's Hospital
Zhengzhou, Henan, China
-
Hunan Children's Hospital
Changsha, Hunan, China
-
Nanjing Children's Hospital
Nanjing, Jiangsu, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
-
The First Hospital of Jilin University
Changchun, Jilin, China
-
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
-
Xi'an Children's Hospital
Xi'an, Shaanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?